Clinical events in a long-term prospective neonatal cohort of children with sickle cell disease: Evidence for a high disease burden without systematic preventive intensification with hydroxyurea.

MLA

Soulié, Alizée, et al. “Clinical Events in a Long-Term Prospective Neonatal Cohort of Children with Sickle Cell Disease: Evidence for a High Disease Burden without Systematic Preventive Intensification with Hydroxyurea.” American Journal of Hematology, vol. 98, no. 12, Dec. 2023, pp. E395–98. EBSCOhost, https://doi.org/10.1002/ajh.27142.

APA

Soulié, A., Kamdem, A., Neumann, F., Hau, I., Madhi, F., Delestrain, C., Shum, M., Carlier-Gonod, A., Malterre, A., Lezeau, H., Khazem, B., Belozertseva, E., Guémas, E., Epaud, R., Pissard, S., Arnaud, C., & Pondarré, C. (2023). Clinical events in a long-term prospective neonatal cohort of children with sickle cell disease: Evidence for a high disease burden without systematic preventive intensification with hydroxyurea. American Journal of Hematology, 98(12), E395–E398. https://doi.org/10.1002/ajh.27142

Chicago

Soulié, Alizée, Annie Kamdem, Florent Neumann, Isabelle Hau, Fouad Madhi, Céline Delestrain, Mickaël Shum, et al. 2023. “Clinical Events in a Long-Term Prospective Neonatal Cohort of Children with Sickle Cell Disease: Evidence for a High Disease Burden without Systematic Preventive Intensification with Hydroxyurea.” American Journal of Hematology 98 (12): E395–98. doi:10.1002/ajh.27142.